GSK
Price
$37.56
Change
-$0.31 (-0.82%)
Updated
Apr 2, 03:58 PM (EDT)
Capitalization
88.13B
28 days until earnings call
OGN
Price
$14.72
Change
+$0.59 (+4.18%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
4.73B
29 days until earnings call
Ad is loading...

GSK vs OGN

Header iconGSK vs OGN Comparison
Open Charts GSK vs OGNBanner chart's image
GSK
Price$37.56
Change-$0.31 (-0.82%)
Volume$5.23K
Capitalization88.13B
Organon & Co
Price$14.72
Change+$0.59 (+4.18%)
Volume$31.65K
Capitalization4.73B
GSK vs OGN Comparison Chart
Loading...
GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GSK vs. OGN commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSK is a Hold and OGN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (GSK: $37.87 vs. OGN: $14.13)
Brand notoriety: GSK and OGN are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GSK: 100% vs. OGN: 105%
Market capitalization -- GSK: $88.13B vs. OGN: $4.73B
GSK [@Pharmaceuticals: Major] is valued at $88.13B. OGN’s [@Pharmaceuticals: Major] market capitalization is $4.73B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GSK’s FA Score shows that 2 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • GSK’s FA Score: 2 green, 3 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, GSK is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GSK’s TA Score shows that 3 TA indicator(s) are bullish while OGN’s TA Score has 2 bullish TA indicator(s).

  • GSK’s TA Score: 3 bullish, 5 bearish.
  • OGN’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, GSK is a better buy in the short-term than OGN.

Price Growth

GSK (@Pharmaceuticals: Major) experienced а -1.84% price change this week, while OGN (@Pharmaceuticals: Major) price change was -4.01% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.44%. For the same industry, the average monthly price growth was -1.53%, and the average quarterly price growth was -6.99%.

Reported Earning Dates

GSK is expected to report earnings on Apr 30, 2025.

OGN is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.44% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GSK($88.1B) has a higher market cap than OGN($4.73B). GSK has higher P/E ratio than OGN: GSK (14.01) vs OGN (4.64). GSK YTD gains are higher at: 13.202 vs. OGN (-3.552). GSK has higher annual earnings (EBITDA): 9.08B vs. OGN (1.44B). GSK has more cash in the bank: 4.99B vs. OGN (693M). OGN has less debt than GSK: OGN (8.76B) vs GSK (18B). GSK has higher revenues than OGN: GSK (30.3B) vs OGN (6.26B).
GSKOGNGSK / OGN
Capitalization88.1B4.73B1,863%
EBITDA9.08B1.44B633%
Gain YTD13.202-3.552-372%
P/E Ratio14.014.64302%
Revenue30.3B6.26B484%
Total Cash4.99B693M720%
Total Debt18B8.76B205%
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
48
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GSKOGN
RSI
ODDS (%)
Bearish Trend 2 days ago
44%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
53%
Momentum
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
57%
MACD
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 6 days ago
54%
Bullish Trend 15 days ago
68%
Declines
ODDS (%)
Bearish Trend 10 days ago
52%
Bearish Trend 6 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 7 days ago
63%
Aroon
ODDS (%)
Bullish Trend 2 days ago
46%
N/A
View a ticker or compare two or three
Ad is loading...
GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLDP1.120.02
+1.82%
Ballard Power Systems
AVB214.51-0.11
-0.05%
AvalonBay Communities
SATS25.19-0.39
-1.52%
EchoStar Corp
ALCO29.38-0.46
-1.54%
Alico
CMMB1.04-0.05
-4.59%
Chemomab Therapeutics Ltd

GSK and

Correlation & Price change

A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSK
1D Price
Change %
GSK100%
-2.25%
NVS - GSK
49%
Loosely correlated
-1.68%
PFE - GSK
47%
Loosely correlated
-3.16%
SNY - GSK
40%
Loosely correlated
-2.02%
JNJ - GSK
40%
Loosely correlated
-7.59%
AZN - GSK
38%
Loosely correlated
-1.22%
More